Lessons learned from experimental models of cerebrovascular aneurysms to improve endocardial device occlusion of the left atrial appendage
In patients with atrial fibrillation, left atrial appendage (LAA) occlusion devices represent an alternative to anticoagulation but are associated with residual peridevice leaks (PDLs) and device-related thrombi (DRT). Similarly, cerebrovascular aneurysms can be treated with coil embolization, but p...
Main Authors: | Subramaniam C. Krishnan, MD, FHRS, Andrea Natale, MD, FHRS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | Heart Rhythm O2 |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666501821001136 |
Similar Items
-
Left Atrial Appendage–Targeted Therapies
by: Antonio Sorgente, MD, PhD
Published: (2020-04-01) -
Termination of anticoagulation therapy at 45 days after concomitant atrial fibrillation catheter ablation and left atrial appendage occlusion resulting in device-related thrombosis and stroke
by: Steven K Carlson, MD, et al.
Published: (2017-01-01) -
Troponin T Elevation After Percutaneous Left Atrial Appendage Occlusion
by: Xiaoyan Wang, et al.
Published: (2021-10-01) -
Combined catheter ablation for atrial fibrillation and Watchman® left atrial appendage occlusion procedures: Five-year experience
by: Karen P. Phillips, MBBS, et al.
Published: (2016-04-01) -
Surgical retrieval of a left atrial appendage closure device (Watchman TM) following embolization into the mitral valve
by: Kevin P Birmingham, et al.
Published: (2019-01-01)